If you loved our Explainer on Cell and Gene Therapy, you'll love this new summarised version. This short report takes you through the key BIA member companies working in the AMR space, and explains the cutting-edge work taking place in the UK.
IMU Biosciences announce their new strategic partnership with Waters Biosciences to accelerate the development of IMU’s next-generation AI-powered High Definition (HD) Immunology Platform. The partnership will bring together Waters Biosciences’ advanced flow cytometry and single-cell technologies with IMU's HD analysis and proprietary AI and machine learning analytics to turn complex immune data into insights at scale across discovery, translational, and clinical research applications.
PrecisionLife has launched Biology Matters, a new podcast exploring how advances in biology, genomics, data science, and AI can help address one of healthcare's greatest challenges: chronic disease.
Poolbeg Pharma has received formal notification of the decision to grant for its POLB 001 cancer immunotherapy-induced Cytokine Release Syndrome (CRS) patent application.
Explore Columbus Global's latest life science report featuring expert into the digital trends shaping the future of Pharma, MedTech and Biotech in 2026 and beyond.
